Device Trial Radar · NCT07924293
A Study to Evaluate the Acceptability of the FemBloc System as a Non-surgical, Permanent Contraceptive Method
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 22, 2025
Primary completion
Apr 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Femasys Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 9, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 21 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Prospective Observational Pilot Study to Evaluate the Acceptability of the FemBloc System as a Non-surgical, Permanent Contraceptive Method in Spain
Conditions
- Contraception
Interventions
FemBloc Permanent Birth ControlDevice
Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Degree of patient satisfactionTime frame: At time of procedure
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Hospital Materno Infantil de Badajoz
Badajoz, Spain
Hospital Universitario de Cruces
Barakaldo, Spain
Hospital Universitario Basurto
Bilbao, Spain
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.